Evidence map›Paper›PMID 41714469›Full record

ArticleThe international journal of cardiovascular imaging2026

Comprehensive multimodal imaging of quadricuspid pulmonary valves: morphology, function, and mid-term prognosis.

Haiyue Xie, Wenhao Zhu, Jingnan Zhang, Zhiyuan Xia, Junyi Wan, Liang Xu, Fang Fang, Aihua Zhi, Bin Lu, Fujian Duan and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Haiyue XieDepartment of Structural Heart Disease, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #167 Bei-Li-Shi Street, 100037, Beijing, People's Republic of China.
Wenhao ZhuDepartment of Structural Heart Disease, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #167 Bei-Li-Shi Street, 100037, Beijing, People's Republic of China.
Jingnan ZhangDepartment of Structural Heart Disease, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #167 Bei-Li-Shi Street, 100037, Beijing, People's Republic of China.
Zhiyuan XiaDepartment of Structural Heart Disease, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #167 Bei-Li-Shi Street, 100037, Beijing, People's Republic of China.
Junyi WanDepartment of Structural Heart Disease, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #167 Bei-Li-Shi Street, 100037, Beijing, People's Republic of China.
Liang XuDepartment of Structural Heart Disease, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #167 Bei-Li-Shi Street, 100037, Beijing, People's Republic of China.
Fang FangDepartment of Structural Heart Disease, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #167 Bei-Li-Shi Street, 100037, Beijing, People's Republic of China.
Aihua ZhiDepartment of Radiology, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #167 Bei-Li-Shi Street, 100037, Beijing, People's Republic of China.
Bin LuDepartment of Radiology, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #167 Bei-Li-Shi Street, 100037, Beijing, People's Republic of China.
Fujian DuanDepartment of Ultrasound, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #167 Bei-Li-Shi Street, 100037, Beijing, People's Republic of China.
Xiangbin PanDepartment of Structural Heart Disease, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #167 Bei-Li-Shi Street, 100037, Beijing, People's Republic of China.
Gejun ZhangDepartment of Structural Heart Disease, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #167 Bei-Li-Shi Street, 100037, Beijing, People's Republic of China. gjzhang212@163.com.

Funding

Capital Health Research and Development of Special Fund 2024-2-4037
6 · The paper itself

Abstract

Quadricuspid pulmonary valve (QPV) is a rare congenital anomaly with limited reports. This study characterizes QPV morphology and function by multimodal imaging, evaluates predictors of moderate-to-severe pulmonary regurgitation (PR), and assesses mid-term prognosis. Retrospective search of the imaging database at a tertiary medical center identified patients diagnosed with QPV between October 2004 and September 2024. Multimodal imaging was utilized to assess the characteristics of QPV and associated abnormalities. Among 1,367,280 cardiac CT and MR exams, 16 patients were diagnosed with QPV (38% male; mean age 43.4 ± 19.7 years). The most common morphology was type D (38%, one larger, two equal intermediate, and one smaller cusps), with cusp fusion in 25% and Becker's type Ⅲ in 13%. Associated congenital heart disease (CHD) occurred in 6 patients (38%). Moderate-to-severe PR was observed in 11 patients (69%), severe pulmonary valve stenosis (PS) in one, and pulmonary artery aneurysm (PAA) in eight (50%). Both regurgitant orifice area (ROA) and main pulmonary artery (PA) dilation increased the risk of moderate-to-severe PR (OR = 2.33, p = 0.048; OR = 1.57, p = 0.041; each 0.25-unit increase). No significant difference was found between QPV classification and PR severity or clinical outcomes. During a median follow-up of 16 (IQR: 2-66) months, no deaths occurred, and 5 patients (31%) underwent surgery. QPV is a rare congenital cardiac malformation with diverse morphologies, predominantly associated with PR and PAA. Approximately one-third of patients required surgery. Multimodal imaging is essential for diagnosis, functional assessment, and management planning for QPV.

Indexed as

Heart Defects, CongenitalMultimodal ImagingPulmonary ValvePulmonary Valve InsufficiencyTomography, X-Ray ComputedAdolescentAdultAgedDatabases, FactualFemaleHumansMaleMiddle AgedPredictive Value of TestsPrognosisRetrospective StudiesMultimodal imagingPulmonary artery dilationPulmonary regurgitationQuadricuspid pulmonary valve

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.